# Biophysical characterization of Eag chaperones suggests the mechanism of effector transmembrane domain release

**Authors:** Matthew Van Schepdael, Iman Asakereh, Jake Colautti, Andrew J. Gierys, Kartik Sachar, Shehryar Ahmad, Mazdak Khajehpour, John C. Whitney, Gerd Prehna

PMC · DOI: 10.1038/s41467-025-68138-w · Nature Communications · 2026-01-22

## TL;DR

This study explores how Eag chaperones release toxic effector proteins in bacteria, revealing the molecular mechanism behind their dissociation.

## Contribution

The study identifies the Eag conformational change and residue contacts that enable TMD release from chaperones.

## Key findings

- Eag chaperones bind effector TMDs with high stability.
- A subtle conformational change in Eag initiates rapid TMD release.
- An X-ray structure captures an intermediate state of TMD release.

## Abstract

The type VI secretion system (T6SS) is a dynamic protein nanomachine found in Gram-negative bacteria that secretes toxic effectors into prey-cells. For secretion, effectors require chaperones or adaptors for proper loading onto the T6SS. Effector associated genes (Eags) are a family of T6SS chaperones that stabilize N-terminal transmembrane domains (TMDs) found in thousands of effectors. Eags are essential for secretion and inhibit effector TMDs from prematurely adopting a membrane-penetrative conformation. However, the mechanism of TMD release from its cognate Eag chaperone is unknown. Here, we take a biochemical and biophysical approach to probe the mechanism of TMD binding and dissociation from Eag chaperones. Using steady-state fluorescence, stopped-flow measurements, and bacterial competition assays, we compare the thermodynamics, kinetics, and in vivo chaperone function of wild-type and point variant Eag-TMD complexes. Additionally, we solve an X-ray crystal structure of an Eag-TMD point variant complex that captures an intermediate state of TMD release. Our data reveals the molecular features and specific residue contacts necessary for TMD binding and demonstrates the Eag conformational change required to initiate rapid release of the TMD. Overall, our work details the stability of Eag-TMD complexes and the energetic pathway for the dissociation of effector TMDs from their Eag chaperones.

The type VI secretion system (T6SS) and Eag chaperones deliver toxic membrane protein effectors into rival cells. However, it is unknown how Eags and their effectors dissociate. Here, the authors show Eag chaperones bind effectors tightly and may release them via a subtle conformational change.

## Linked entities

- **Genes:** KCNH1 (potassium voltage-gated channel subfamily H member 1) [NCBI Gene 3756]

## Full-text entities

- **Genes:** KCNH1 (potassium voltage-gated channel subfamily H member 1) [NCBI Gene 3756] {aka EAG, EAG1, K(V)10.1, Kv10.1, TMBTS, ZLS1}
- **Diseases:** toxicity (MESH:D064420)
- **Chemicals:** tryptophan (MESH:D014364), agarose (MESH:D012685), kanamycin (MESH:D007612), ampicillin (MESH:D000667), Imidazole (MESH:C029899), SDS (MESH:D012967), ADP (MESH:D000244), nitrogen (MESH:D009584), nickel (MESH:D009532), metal (MESH:D008670), guanidine hydrochloride (MESH:D019791), BME (-), 5-bromo-4-chloro3-indolyl-beta-D-galactopyranoside (MESH:C044888), MgCl2 (MESH:D015636), urea (MESH:D014508), ox-bile (MESH:D020358), sucrose (MESH:D013395), irgasan (MESH:C005055), gentamicin (MESH:D005839), streptomycin (MESH:D013307), alanine (MESH:D000409), hydrogen (MESH:D006859), Coomassie Brilliant Blue (MESH:C004692), NADP+ (MESH:D009249), NaCl (MESH:D012965), NAD+ (MESH:D009243), PBS (MESH:D007854), agar (MESH:D000362), MES (MESH:C004550), bile-salts (MESH:D001647), 2-Mercaptoethanol (MESH:D008623), PEG 6000 (MESH:C000595215)
- **Species:** Escherichia coli DH5[alpha] (strain) [taxon 668369], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Pseudomonas aeruginosa PAO1 (strain) [taxon 208964], Pseudomonas aeruginosa (species) [taxon 287], Escherichia coli BL21(DE3) (strain) [taxon 469008]
- **Mutations:** I24, A66, Q102A, I24F, leucine to alanine, Q102, Q58A, L66, A24, Q58, L66A, tryptophan at 280
- **Cell lines:** SM10 — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_7004), pET-29b — Homo sapiens (Human), Amyotrophic lateral sclerosis 1, Induced pluripotent stem cell (CVCL_9000), BL21(DE3)-Gold — Mus musculus (Mouse), Hybridoma (CVCL_B7HM)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881460/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881460/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881460/full.md

---
Source: https://tomesphere.com/paper/PMC12881460